| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Revenue | $1.18B | +98.4% |
| Cost of Revenue | $987.2M | +100.0% |
| Gross Profit | $189.7M | +90.4% |
| R&D Expense | $195.0M | +57.1% |
| SG&A Expense | $217.9M | +88.1% |
| Operating Income | -$223.2M | -59.0% |
| Pre-tax Income | -$212.5M | -52.8% |
| Income Tax | -$4.6M | — |
| Net Income | -$23.9M |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $258.8M | -26.8% |
| Accounts Receivable | $69.2M | +1928.3% |
| Inventory | $136.1M | +48.1% |
| Current Assets | $991.8M | +63.8% |
| Total Assets | $1.05B | +66.4% |
| Current Liabilities | $1.03B | +96.1% |
| Total Liabilities | $1.05B | +87.3% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $230.8M | +255.7% |
| Capital Expenditures | $15.7M | -12.6% |
| Investing Cash Flow | -$299.5M | -1568.3% |
| Financing Cash Flow | -$24.1M | -106.6% |
| Free Cash Flow | $215.1M | +229.4% |
| +66.9% |
| EPS (Basic) | -$0.37 | -184.6% |
| EPS (Diluted) | -$0.37 | -184.6% |
| Stockholders' Equity |
| $82K |
| -98.9% |